腔内时代足背动脉旁路术的分析
本研究回顾性比较2000-2022年足背动脉旁路术(DPB)与胫动脉PTA/S治疗慢性肢体威胁性缺血的结局。倾向筛选后,DPB与PTA/S围术期并发症无差异,远期结局相似;但采用单段大隐静脉的DPB显示更高的伤口愈合率和更低的截肢/死亡风险。
要点
- DPB与胫动脉PTA/S围术期并发症和远期结局总体相似。
- 单段大隐静脉DPB较PTA/S提高6个月伤口愈合率并降低5年截肢/死亡。
- 非单段大隐静脉DPB的畅通率丢失风险较PTA/S高约50%。
核心结论
- DPB仍提供持久的修复效果,围术期并发症与胫动脉PTA/S相似。
- 采用单段大隐静脉的DPB可能提高伤口愈合率并降低截肢或死亡风险。
研究设计与样本
- 回顾性队列研究,纳入2000-2022年在本机构接受DPB或胫动脉PTA/S的患者。
- 分析限制于2005年后因慢性肢体威胁性缺血手术且符合旁路条件的PTA/S患者(TASC C或D病变、造影有潜在DPB靶血管)。
- 符合标准者包括259例DPB和329例胫动脉PTA/S。
- 采用χ2、Kaplan-Meier和Cox回归分析。
主要发现
- DPB患者更常为白人(76% vs 64%)、男性(73% vs 52%)和表现为组织缺损(91% vs 84%),均P < .05。
- 围术期并发症无差异:死亡率1.9% vs 3.9%,心肌梗死1.9% vs 2.1%,急性肾损伤5.8% vs 10%(均P > .05)。
- DPB与PTA/S的6个月完全伤口愈合率分别为43%和32%(P = .07),远期再干预、大截肢、主要不良肢体事件和截肢/死亡均无差异(均P > .05)。
- 单段大隐静脉DPB(n=213)对比PTA/S:6个月伤口愈合率46% vs 32%(P = .03),5年截肢/死亡57% vs 66%(P = .04),Cox回归HR分别为1.55(95%CI 1.03-2.34)和0.73(95%CI 0.54-0.97)。
- 非单段大隐静脉DPB(n=47)对比PTA/S:畅通率丢失风险约高50%(HR 0.49;95%CI 0.25-0.98)。
临床怎么用
- 对于慢性肢体威胁性缺血且适合旁路的患者,DPB仍是有效的血运重建选择。
- 优先考虑使用单段大隐静脉进行DPB,以可能改善伤口愈合和降低截肢/死亡。
- 非单段大隐静脉DPB需警惕畅通率丢失风险较高。
局限性
- 回顾性研究设计。
- 分析限制于特定人群和时段,可能影响普遍性。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
BACKGROUND: Our institution previously reported excellent short- and long-term outcomes after dorsalis pedis bypass (DPB) for ischemic limb salvage; however, since then, percutaneous transluminal angioplasty with or without stenting (PTA/S) has become the more common management approach. This study aims to describe our nearly 20-year experience with DPB to compare the short- and long-term outcomes between these two revascularization strategies in patients with chronic limb-threatening ischemia. METHODS: All patients undergoing DPB or tibial PTA/S between 2000 and 2022 at our institution were retrospectively reviewed. Primary outcomes included perioperative complications, complete wound healing, reintervention, major amputation, major adverse limb events, and a composite variable of major amputation or death (amputation/death). For a more direct comparison, analyses were restricted to procedures performed for chronic limb-threatening ischemia and after the introduction of PTA/S (2005) and to PTA/S patients that were suitable candidates for bypass, had Trans-Atlantic Inter-Society Consensus C or D disease, and a potential DPB target on angiography. Outcomes were evaluated using χ2, Kaplan-Meier, and Cox regression analyses. RESULTS: Between 2000 and 2010, 462 DPB and 395 tibial PTA/S were performed; between 2011 and 2022, 101 DPB and 955 tibial PTA/S were performed. Of those, 259 DPB and 329 tibial PTA/S fit our criteria. Compared with tibial PTA/S patients, DPB patients were similar in age (69.9 years vs 70.8 years) yet were more often White (76% vs 64%) and male (73% vs 52%), and more commonly presented with tissue loss (91% vs 84%) (all P < .05). There were no differences in perioperative complications, including mortality (1.9% vs 3.9%), myocardial infarction (1.9% vs 2.1%), or acute kidney injury (5.8% vs 10%) (all P > .05). Between DPB and PTA/S, despite a trend toward higher rates of complete wound healing after DPB (6-month rate: 43% vs 32%; P = .07), no long-term outcome differences were seen, including reintervention (5-year rate: 41% vs 40%), major amputation (25% vs 24%), major adverse limb events (42% vs 40%), or amputation/death (59% vs 66%) (all P > .05). A sensitivity analysis comparing DPB with single-segment great saphenous vein (ssGSV; n = 213) vs tibial PTA/S demonstrated that DPB had higher rates of complete wound healing (6-month rate: 46% vs 32%; P = .03) and lower rates of amputation/death (5-year rate: 57% vs 66%; P = .04), both of which remained significant after Cox regression (hazard ratio [HR], 1.55 [95% confidence interval, 1.03-2.34] and HR, 0.73 [95% CI, 0.54-0.97], respectively). Conversely, non-ssGSV DPB (n = 47), compared with tibial PTA/S, were approximately 50% more likely to experience loss of patency (HR, 0.49; 95% CI, 0.25-0.98). CONCLUSIONS: Although becoming less common, DPB still provides a durable repair, results in similar perioperative complications compared with tibial PTA/S, and, when performed with ssGSV, may result in higher rates wound healing and lower rates amputation or death. Ultimately, despite the notable decrease in DPB in the endovascular era, these data demonstrate the importance of both revascularization strategies in treating distal arterial disease.
引用
- Darling JD, van Galen IF, Caron E, et al. Analysis of dorsalis pedis bypass in the endovascular era. J Vasc Surg. 2025. PMID: 40744207. doi:10.1016/j.jvs.2025.07.036
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。